Reliability of <it>KRAS</it> mutation testing in metastatic colorectal cancer patients across five laboratories
<p>Abstract</p> <p>Background</p> <p>Mutations in the <it>KRAS</it> gene are associated with poor response to epidermal growth factor receptor inhibitors used in the treatment of metastatic colorectal cancer. Factors influencing <it>KRAS</it> tes...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-04-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1756-0500/5/196 |